CLINICAL FEATURES AND UNDERLYING FACTORS OF INSOMNIA  IN PATIENTS WITH NEUROLOGICAL DISORDERS

Tolibova Muhabbat Murod qizi

##article.authors##

Tolibova Muhabbat Murod qizi ##default.groups.name.author##

##semicolon##

Keywords: insomnia, neurological disorders, sleep disturbance, ISI, polysomnography, Parkinson’s disease, epilepsy, multiple sclerosis, stroke, cognitive behavioral therapy

##article.abstract##

Abstract. Insomnia is a common yet often underdiagnosed condition among patients with neurological disorders, significantly affecting their overall quality of life and disease progression. This study aimed to evaluate the clinical presentation, underlying causes, and management outcomes of insomnia across different neurological conditions, including Parkinson’s disease, epilepsy, multiple sclerosis, and post-stroke states. Eighty patients aged 25 to 55 were clinically assessed using the Insomnia Severity Index (ISI), structured interviews, and, for a subset, overnight polysomnography. Participants were divided into four diagnostic groups to analyze the prevalence and severity of insomnia symptoms, contributing factors such as medication side effects, anxiety, neuropathic pain, and seizure activity. The findings revealed that sleep disturbances were widespread, with significant intergroup variations. Polysomnography confirmed substantial alterations in sleep architecture. Among the therapeutic interventions, cognitive behavioral therapy (CBT) proved to be the most effective. The study highlights the importance of comprehensive and tailored approaches to insomnia management in neurological patients, underscoring the need for integrated neurological and psychological care.

##submission.citations##

1. Ohayon M. M. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Medicine Reviews. 2002;6(2):97–111.

2. Winkelman J. W. Clinical and polysomnographic features of sleep disturbances in patients with neurological disorders. Neurologic Clinics. 2005;23(4):1041–1056.

3. Chokroverty S. Sleep Disorders Medicine: Basic Science, Technical Considerations, and Clinical Aspects. Springer, 2017.

4. Trotti L. Insomnia in patients with Parkinson’s disease. Journal of Neural Transmission. 2018;125(3):443–450.

5. Montagna P., Gambetti P., Cortelli P., Lugaresi E. Clinical features of fatal familial insomnia. Sleep. 2003;26(8):887–893.

6. Bazil C. W. Sleep and epilepsy. Current Opinion in Neurology. 2000;13(2):171–175.

7. Veauthier C., Paul F. Sleep disorders in multiple sclerosis and their relationship to fatigue. Sleep Medicine. 2014;15(1):5–14.

8. Bakker F. C., van Dijk J. G., van Zandvoort M. J. Early waking and fragmented sleep in stroke patients: prevalence and associated factors. European Neurology. 2010;63(2):103–109.

9. Morin C. M., Benca R. Chronic insomnia. Lancet. 2012;379(9821):1129–1141.

10. Edinger J. D., Means M. K. Cognitive-behavioral therapy for primary insomnia. Clinical Psychology Review. 2005;25(5):539–558.